Search
Toxoplasma gondii encephalitis
go.drugbank.com/conditions/DBCOND0020764Drugs: AtovaquoneSynonyms: Meningoencephalitis due to toxoplasmosis, Meningoencephalitis due to acquired toxoplasmosis (disorder)Congenital leptin deficiency
go.drugbank.com/conditions/DBCOND0158112Drugs: MetreleptinSynonyms: Obesity due to congenital leptin deficiencySerine
go.drugbank.com/drugs/DB00133ApprovedInvestigationalNutraceuticalA non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.
Mixtures: PEDASEL %10 AMİNO ASİT ÇÖZELTİSİ, 100 ML, PRIMENE %10 İNFÜZYONLUK PEDİYATRİK AMİNOASİT ÇÖZELTİSİ, 100 MLGranuloma Inguinale
go.drugbank.com/conditions/DBCOND0005915Synonyms: Infection due to Donovania granulomatis, Infection due to Calymmatobacterium granulomatisMalignant Edema
go.drugbank.com/conditions/DBCOND0062033Drugs: BenzylpenicillinSynonyms: Gas gangrene due to Clostridia, Gas gangrene due to Clostridia, NOSTaurine
go.drugbank.com/drugs/DB01956ApprovedInvestigationalNutraceutical[A31396] This conditional amino acid can be either be manufactured by the body or obtained in the diet mainly by the consumption of fish and meat. … [L1058] The supplements containing taurine were FDA approved by 1984 and they are hypertonic injections composed by cristalline amino acids.[FDA label]
Mixtures: PEDASEL %10 AMİNO ASİT ÇÖZELTİSİ, 100 ML, PRIMENE %10 İNFÜZYONLUK PEDİYATRİK AMİNOASİT ÇÖZELTİSİ, 100 MLProctitis, Ulcerative
go.drugbank.com/conditions/DBCOND0122484Drugs: MesalazineSynonyms: Ulcerative colitis confined to rectum, UC - Ulcerative colitis confined to rectumMycobacterium kansasii infection
go.drugbank.com/conditions/DBCOND0013998Synonyms: Infection due to Mycobacterium kansasii (disorder)Digoxin toxicity
go.drugbank.com/conditions/DBCOND0020459Drugs: Digoxin Immune Fab (Ovine)Synonyms: Toxicity to various agentsFerric maltol
go.drugbank.com/drugs/DB15598ApprovedInvestigational[L10974] On December 22, 2025, the FDA expanded this indication to include pediatric patients aged 10 years and older. [L54873,L54878] … Ferric maltol is an iron(III) atom complexed with 3 maltol molecules to increase the bioavailability compared to iron(II), without depositing it in the duodenum as insoluble ferric hydroxide and phosphate